[Should bisphosphonate treatment be used for super-old patients with osteoporosis?].
Harada
Atsushi
A
Yamamoto
Seizo
S
Kurato
Shigeyuki
S
Iwase
Toshiki
T
Inoue
Kikuo
K
Sasaki
Yasuo
Y
Tanaka
Takaaki
T
Fujita
Masaki
M
Nakano
Tetsuo
T
Ando
Fujiko
F
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D005260:Female; D005598:Fractures, Spontaneous / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000378:metabolism; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control*
D050071:Bone Density Conservation Agents; D006887:Hydroxycholecalciferols; C008088:alfacalcidol; D019386:Alendronate